سعر Xefo 4 mg 20 f.c. tabs 2026
دواعي استعمال Xefo 4
- Short-term relief of acute mild to moderate pain.الفئة: AdultsHealth Products Regulatory Authority (HPRA), Ireland
- Symptomatic relief of pain and inflammation in osteoarthritis.الفئة: AdultsHealth Products Regulatory Authority (HPRA), Ireland
- Short-term relief of acute mild to moderate pain.Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland
- Symptomatic relief of pain and inflammation in osteoarthritis.Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland
معلومات الدواء
التفاصيل الكاملةالآثار الجانبيةSide effects
- About 20% of patients may experience adverse reactions; most frequent are nausea, dyspepsia, indigestion, abdominal pain, vomiting and diarrhoea (generally under 10%).نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA), Ireland
- About 20% of patients may experience adverse reactions; most frequent are nausea, dyspepsia, indigestion, abdominal pain, vomiting and diarrhoea (generally under 10%).International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
موانع الاستعمالContraindications
- Hypersensitivity to lornoxicam or excipients; thrombocytopenia; hypersensitivity (asthma, rhinitis, angioedema, urticaria) to other NSAIDs including aspirin; severe heart failure; GI, cerebrovascular or other bleeding disorders; history of NSAID-related GI bleeding/perforation; active or recurrent peptic ulcer; severe hepatic impairment; severe renal impairment (serum creatinine >700 µmol/L); third trimester of pregnancy.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA), Ireland
- Hypersensitivity to lornoxicam or excipients; thrombocytopenia; hypersensitivity (asthma, rhinitis, angioedema, urticaria) to other NSAIDs including aspirin; severe heart failure; GI, cerebrovascular or other bleeding disorders; history of NSAID-related GI bleeding/perforation; active or recurrent peptic ulcer; severe hepatic impairment; severe renal impairment (serum creatinine >700 µmol/L); third trimester of pregnancy.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
تحذيرات واحتياطاتWarnings & precautions
- Use with careful risk-benefit assessment in mild to moderate renal impairment, coagulation disorders, hepatic impairment and in the elderly; avoid combination with other NSAIDs including COX-2 inhibitors; use the lowest effective dose for the shortest duration.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA), Ireland
- Use with careful risk-benefit assessment in mild to moderate renal impairment, coagulation disorders, hepatic impairment and in the elderly; avoid combination with other NSAIDs including COX-2 inhibitors; use the lowest effective dose for the shortest duration.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
الحمل والرضاعةPregnancy & breastfeeding
- Contraindicated in the third trimester; should not be used in the first and second trimesters or during delivery because no clinical data on exposed pregnancies are available.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA), Ireland
- No human data; lornoxicam is excreted in rat milk in relatively high concentrations, so it should not be used in breastfeeding women.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA), Ireland
- Contraindicated in the third trimester; should not be used in the first and second trimesters or during delivery because no clinical data on exposed pregnancies are available.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
- No human data; lornoxicam is excreted in rat milk in relatively high concentrations, so it should not be used in breastfeeding women.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
تابع أسعار الأدوية أول بأول
بننشر كل يوم أسعار أدوية اتغيرت والبدائل الأرخص
المثائل (5)
كل المثائل والبدائلنفس المادة الفعالة والتركيز. اسأل الصيدلي قبل الاستبدال.
| الدواء | السعر | الفرق عن الأصلي |
|---|---|---|
| لورنوكس 4 مجم 10 أقراصLornox 4mg 10 f.c. tabsEGPI · أقراص مغلفة · 4 mgالأرخص | السعر7ج.م0.7ج.م للوحدة | الفرق عن الأصليأرخص 16.25ج.م (69.9%) |
| زيفيكام 4مجم 20 قرصZeficam 4mg 20 f.c. tabsEva Pharma · أقراص مغلفة · 4 mg | السعر13ج.م0.65ج.م للوحدة | الفرق عن الأصليأرخص 10.25ج.م (44.1%) |
| توبرانو 4مجم 20 قرصToprano 4mg 20 f.c.tabDelta Pharma · أقراص مغلفة · 4 mg | السعر14ج.م0.7ج.م للوحدة | الفرق عن الأصليأرخص 9.25ج.م (39.8%) |
| روكسيكام 4مجم 20 اقراصRheuxicam 4mg 20 f.c.tabChemipharm · 4 mg | السعر25.5ج.م1.28ج.م للوحدة | الفرق عن الأصليأغلى 2.25ج.م (9.7%) |
| لورنيكام 4مجم 30 قرصLornicam 4 mg 30 tabsMira international · أقراص · 4 mg | السعر66ج.م2.2ج.م للوحدة | الفرق عن الأصليأغلى 42.75ج.م (183.9%) |
المعرّفات
- الباركود
- 6224000335038
أدوية ذات صلة
نفس المادة الفعالة بتركيز آخر
منتجات أخرى من Takeda
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- Health Products Regulatory Authority (HPRA), Ireland
تعليقات
لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.
أضف تعليقًا